XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net revenues $ 2,295 $ 2,486 $ 6,964 $ 7,550
Operating costs and expenses and other operating income:        
Cost of services 1,541 1,618 4,647 4,875
Selling, general and administrative 380 464 1,235 1,311
Amortization of intangible assets 27 27 81 81
Other operating expense (income), net 5 (15) 6 (10)
Total operating costs and expenses, net 1,953 2,094 5,969 6,257
Operating income 342 392 995 1,293
Other income (expense):        
Interest expense, net (40) (33) (112) (106)
Other (expense) income, net (3) (8) 10 (61)
Total non-operating expense, net (43) (41) (102) (167)
Income before income taxes and equity in earnings of equity method investees 299 351 893 1,126
Income tax expense (68) (81) (208) (268)
Equity in earnings of equity method investees, net of taxes 6 6 18 41
Net income 237 276 703 899
Less: Net income attributable to noncontrolling interests 12 20 41 54
Net income attributable to Quest Diagnostics $ 225 $ 256 $ 662 $ 845
Earnings per share attributable to Quest Diagnostics’ common stockholders:        
Basic (in dollars per share) $ 1.99 $ 2.20 $ 5.87 $ 7.17
Diluted (in dollars per share) $ 1.96 $ 2.17 $ 5.79 $ 7.05
Weighted average common shares outstanding:        
Basic (in Shares) 112 116 112 117
Diluted (in Shares) 114 118 114 119